News
- Author:
- Sara Freeman
Publish date: August 30, 2021
People with psoriasis had a lower risk for psoriatic arthritis if they had been treated with a biologic than if they had not, based on a study of e...
News
- Author:
- Sara Freeman
Publish date: July 20, 2021
Vertebral, not other, osteoporotic fractures were increased in current versus past users of low-dose steroids in a retrospective cohort study.
News
- Author:
- Sara Freeman
Publish date: July 14, 2021
Mirabegron, sofosbuvir, and nintedanib join a list of 12 other drugs that have been linked to an overreporting of drug-associated ANCA vasculitis.<...
News
- Author:
- Sara Freeman
Publish date: June 11, 2021
It could take 2-4 years before plain radiographs show any sign of a benefit on the spine or sacroiliac joints.
News
- Author:
- Sara Freeman
Publish date: June 10, 2021
The granulocyte/macrophage-colony stimulating factor (GM-CSF) blocker reduced the need for mechanical ventilation and death by day 29 versus placeb...
News
- Author:
- Sara Freeman
Publish date: June 8, 2021
Risk mitigation strategies such as social distancing and wearing masks, especially indoors, remain important for people being treated with rituxima...
News
- Author:
- Sara Freeman
Publish date: June 7, 2021
Biosimilars, Janus kinase inhibitors, and interleukin-23 inhibitors will feature in the 2021 update.
News
- Author:
- Sara Freeman
Publish date: June 3, 2021
Results from a phase 2b trial are “clearly encouraging” and “support the hypothesis that BAFF [B-cell–activating factor] can drive flares after rit...
News
- Author:
- Sara Freeman
Publish date: June 3, 2021
Conclusions drawn from a systematic literature review largely appear to reinforce the recommendations that have already been made but need further ...
News
- Author:
- Sara Freeman
Publish date: June 2, 2021
Pooled data from phase 1 and 2 trials show that rates of interstitial lung disease in metastatic breast cancer pa...
News
- Author:
- Sara Freeman
Publish date: May 26, 2021
High-risk patients may gain most benefit from goserelin while low-risk patients may be better off with tamoxifen,...
News
- Author:
- Sara Freeman
Publish date: May 19, 2021
First results from the phase 2, single-arm study suggest immune induction with an atezolizumab and carboplatin co...
News
- Author:
- Sara Freeman
Publish date: May 19, 2021
Similar survival results were seen in the phase 2 study that compared the preop use of the combination or standar...
News
- Author:
- Sara Freeman
Publish date: May 13, 2021
Few cardiac events were seen at 5-year follow-up in patients treated with pertuzumab-trastuzumab and neoadjuvant ...
News
- Author:
- Sara Freeman
Publish date: May 7, 2021
Co-use of co-trimoxazole decreased the risk for infection, which remains high in patients with vasculitis who are treated with rituximab.
